Insmed Incorporated (INSM) saw a big move last session, as the company’s shares fell by nearly 27% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for INSM, as the stock is now down 36.7% in the past one-month time frame.
Insmed has seen a flat track record when it comes to current year estimate revisions over the past few weeks (no increase, no decrease), and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.
INSM currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the pharmaceutical sector include Actelion Ltd. (ALIOF), Anthera Pharmaceuticals, Inc. (ANTH) and Curis, Inc. (CRIS). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment